WINDLAS
Windlas
Live Price
₹857.95
-3.50-0.41%
Conviction Scorecard
AI Momentum
83%Technical Rating
55%Analyst Sentiment
85%Market News & Buzz
📰
Recent news and updates for WINDLAS will appear here soon.
Stockmo Analyst Rationale
AI Generated Insight
"Robust technical setup for WINDLAS with strong AI conviction. The bullish trend in the healthcare space is accelerating while RSI at 55 suggests there is still significant room for upside before reaching overbought territory."
Verified by Stockmo Intelligence Grid
Supporting Evidence
Citing cross-referenced internal documents and market technicals
About Windlas
Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India. The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services. It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable and dispersible tablets, customized generics, and complex generics and multi-drug combinations, as well as injectables, including liquid vials, lyophilized vials, and ampoules. In addition, the company offers generic drugs for respiratory, anti-diabetic, gastroenterology, cardiovascular and multivitamin, neuro anti-psychotic, diabetic care, nutraceuticals, nutritional supplement, urology, pain management, and injectable therapies. It also exports generic medicines, health supplements, and custom-branded formulations. Windlas Biotech Limited was incorporated in 2001 and is headquartered in Dehradun, India.
Frequently asked questions
As of the latest market session, Windlas (WINDLAS) is trading at ₹857.95, representing a move of -0.41% from the previous close.
Windlas is listed and traded under the ticker symbol WINDLAS on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Windlas's stock price moved by -0.41%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 83% bullish probability for WINDLAS stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Windlas shares reached a high of ₹1,097.9 and hit a low of ₹697.4.
WINDLAS exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 31,663 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Windlas has a market capitalization of ₹1770.49 Cr, designating its size class inside the Healthcare sector.
Windlas has a current dividend yield of 73.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Windlas's trailing Price-to-Earnings (P/E) ratio is 27.55. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Windlas (WINDLAS) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Windlas's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore WINDLAS's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for WINDLAS are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Windlas operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.